The AIDS Institute was established in November 2007 to take HKU in a new strategic direction in fighting the global AIDS epidemic and help to make it a leader in the region in AIDS research, education and prevention. Scientists at the AIDS Institute are fully committed to conducting basic and applied research that facilitates the understanding of AIDS pathogenesis and the development of effective AIDS vaccines. Activities in the Institute include basic research to examine the virological and immunological mechanisms underlying HIV pathogenesis; new conception, design, preparation and laboratory testing of vaccine candidates for HIV and other infectious diseases; and monitoring the evolution of HIV epidemic in Hong Kong and in the region.
The Bau Institute of Medical and Health Sciences Education (BIMHSE) was inaugurated in 2004 to underscore the Faculty’s dedication to educational excellence, and entrusted with a mission to promote excellence, professionalism, innovation and collaboration in medical and health sciences education. To further achieve these aims, BIMHSE has recently restructured its core programmes to focus on Pedagogy and Training, Research and Scholarship and Innovation and Collaboration. These core programmes are led by directors and members with expertise, experience and commitment to medical education and who represent a cross-section of specialties including basic sciences, Medicine, Nursing, Chinese Medicine and Pharmacy. With a broad-base of support and well-defined areas of concentration, BIMHSE continues to consolidate its position as a leader in the field, influencing the progress and quality of medical and health sciences education locally, regionally and abroad.
The Carol Yu Centre for Infection aims to bring the fruits of research to clinicians and the public by education, and in turn improve clinical service and health. With the vision to be a leading centre of excellence for research, education and clinical service in the area of emerging infectious disease for China, clinicians and scientists at the Centre are committed to making scientific discoveries to control the problem of emerging infectious diseases. It conducts research on the understanding of pathogenesis, diagnostics, antimicrobials and vaccination of emerging infectious diseases and the causative microbial agents.
The Centre for the Humanities and Medicine was established in 2009 as a joint initiative between the Faculty of Arts and the Li Ka Shing Faculty of Medicine at The University of Hong Kong. The Centre is the first institution of its kind in Asia, and one of the few in the world with a mission to foster interdisciplinary research and teaching in relation to three broad interconnected themes: the challenges posed by the translation of biomedical technologies into society; the relationship between disease, health, culture and society; and the humanization of our understanding and practice of medicine.
The Centre for Medical Ethics and Law was established in 2012 as a joint initiative between the Faculty of Law and the Li Ka Shing Faculty of Medicine at The University of Hong Kong. Its primary vision is to become a focal point for international research excellence in the area of medical ethics and law; to co-ordinate and provide teaching and training to university students and professionals; and to promote and disseminate its expertise to the benefit of the public. As the ethics of medical practice and research has become increasingly exposed to public and legal scrutiny, the Centre will also provide a leading forum for discussing issues of public interest and concern to Hong Kong society.
The Centre of Influenza Research fosters research excellence on influenza and related diseases through a multi-disciplinary research program with the integration of basic, clinical and epidemiological research spanning the animal-human interface. The major research aims are to understand the evolution of human and animal influenza viruses and pandemic emergence; to investigate how influenza viruses transmit and cause disease; to develop evidence-based options for the control of influenza in humans and animals by defining the transmission dynamics and quantifying the impact of interventions; and to develop novel options for diagnosis, vaccines and therapy.
(The website of the Centre will be provided soon.)
Clinical Trials Centre is a leading academic research organisation dedicated to one-stop clinical research solutions. We are committed to enhancing global healthcare by promoting the quality and efficiency of clinical research and testing of new chemical drugs, biologics, vaccines, traditional Chinese medicines, medical devices and diagnostic tools through ethical consideration, scientific expertise, quality assurance and education. Our core competences range from academic research consultation, training and education to protocol development, feasibility assessment and site identification, regulatory affairs, finance and contract management, project management and monitoring, data management, medical statistics, and central laboratory support for industry-sponsored clinical studies.
The Emergency Medicine Unit (EMU) was established in November 2014. The unit aims to become a hub of teaching and research of Emergency Medicine in the Asia Pacific region.
The staff of EMU are responsible for the teaching of medical students in Emergency Medicine in the MBBS curriculum. As EMU is a key strategic partner of the Hong Kong Jockey Club Disaster Preparedness and Response Institute at the Hong Kong Academy of Medicine, it also contributes to the development of Disaster Medicine in Hong Kong. The professoriate staff of EMU provide specialist clinical services at the 24 hour Outpatient and Emergency Department of the Gleneagles (Hong Kong) Hospital and the Accident & Emergency Department of Queen Mary Hospital. The unit also has close collaboration with the Accident & Emergency Department of the HKU-Shenzhen Hospital in teaching and research.
The HKU-Pasteur Research Centre, a joint partnership between The University of Hong Kong and Institut Pasteur, has been established in 2000 with the aim to build a program of excellence in the study of infectious diseases. The Centre has developed competitive research projects with a strong regional focus to study the interactions between pathogens and host cells, which are the battlefields of infections, with cutting edge experimental approaches. We study infectious diseases that may have devastating effect on public health and the economy of the community, with major emphasis on respiratory infections and the mosquito borne disease of dengue. The overarching goal of the Centre is to create basic knowledge that will be applied to human diseases and to foster education through advanced international Master Classes that attract students and faculty from all over the world.
The Institute of Cardiovascular Science and Medicine (ICSM) commits itself to strive for excellence in research, teaching and training in cardiovascular sciences which contributes to the prevention and patient management of cardiovascular diseases in Hong Kong. Established by a group of cardiovascular researchers in June 1996, ICSM aims to achieve academic/research excellence in cardiovascular sciences and medicine, which would bring international recognition, and at the same time, reduce the mortality and morbidity of cardiovascular disease.
The Laboratory Animal Unit (LAU) is a service unit of Li Ka Shing Faculty of Medicine. The Unit was established in 1979. The primary function of the LAU is the breeding of specific pathogen free laboratory animals for research and teaching, mainly for the Faculty of Medicine, although animals are also supplied to other University departments and units. Centralised animal holding and surgical facilities for biomedical research are also provided. The Unit also advises on matters relating to laboratory animal science and provides veterinary service to all departments and units of the University.
The Medical Ethics and Humanities Unit (MEHU) was formed in 2012 to provide a conceptual and structural home for the two interrelated Faculty-based longitudinal programmes. The major function of the MEHU is to develop, integrate and coordinate the teaching and learning in ethics and humanities within the medical curriculum while complementing the existing disciplinary teaching. While the curricula of the Medical Ethics and Medical Humanities have distinctive features, they share common goals, an important component of which is medical professionalism in students and doctors.
The mission of the Research Centre of Heart, Brain, Hormone & Healthy Aging is to enhance and extend human health span, and improve the quality of life in the ageing population, through excellence in biomedical research. This is well achieved through the provision of a stimulating and collegial environment for a comprehensive and multi-disciplinary effort to ageing related research. The Centre aims at developing novel therapeutic and diagnostic approaches for the promotion of healthy ageing, through synergistic interaction and inter-laboratory collaboration. To enhance the critical mass on healthy ageing research in Hong Kong, the Centre will also strive to offer excellent training opportunities and postgraduate education, in both laboratory-based research and clinical medicine, on ageing related diseases.
Investigators of the Centre pursue in-depth and innovative research on ageing diseases of the cardiovascular, neurological and endocrine systems, using the tools of modern laboratory and clinical research. The Centre focuses on four major research themes:
- degeneration and regeneration;
- diabetes and metabolic syndrome;
- vascular biology; and
- cell therapy and tissue engineering.
Numerous currently incurable human diseases arise from the loss or malfunction of highly specialised cell types that lack the capacity to regenerate (e.g., heart and brain cells) due to disease, trauma or ageing (such as cardiovascular disease, spinal cord injury, etc). Human embryonic stem cells (hESC) uniquely possess the ability to self-renew (and therefore can function as an unlimited cell factory) and the potential of becoming ALL cell types of the body (i.e., pluri-potency), thereby offering unprecedented new hope; most recently, direct reprogramming of adult skin cells to become pluripotent ES-like cells (a.k.a. induced pluripotent stem cells or iPSCs) has been achieved, freeing potential ethical concerns and making ES/iPS cell-based therapies another step closer to reality.
The Stem Cell and Regenerative Medicine Consortium at HKU has the following long-term visions:
- To prolong the human life span and to improve the quality of life via successful hESC/iPSC-related research;
- To provide a collegial and intellectually stimulating environment for a comprehensive and multi-disciplinary Stem Cell and Regenerative Medicine Consortium;
- To make significant, long half-life fundamental discoveries of high academic and scientific value in the hESC/iPSC field;
- To develop novel commercially-viable and marketable therapeutic approaches that can directly benefit patients and the economy of HKSAR via translational research; and
- To foster the field by offering excellent training opportunities and education to nurture the next-generation scientists, clinicians and academicians.
Our mission is to establish an internationally renowned, highly-specialised academic programme in Regenerative Medicine that functions as a stem cell hub for attracting regional and foreign talents, and to serve as a bridge between China and Western countries. SCRMC is devoted to support and promote collaborations between basic, translational and clinical faculty specialised in diseases of different disciplines. A goal is to enable researchers from HKU and elsewhere to most effectively translate basic scientific discovery into practicable applications.